Faculty of Medicine, Northern Ontario School of Medicine, Sudbury, ON, Canada.
Department of Surgery, Health Sciences North, Sudbury, ON, Canada.
Tech Coloproctol. 2018 Jun;22(6):433-443. doi: 10.1007/s10151-018-1812-3. Epub 2018 Jun 28.
Transanal total mesorectal excision (taTME) is a safe and effective technique. We have progressively developed a systematic approach in the single-surgeon setting. The aim of this study was to compare our early vs late single-surgeon taTME experience as well as present the technical and logistical modifications that were crucial to achieve successful implementation of a taTME program.
Review of prospectively collected data on 27 patients who had taTME in June 2015-September 2016 (early cohort) was included and compared with 43 patients who underwent taTME in October 2016-September 2017 (late cohort). Procedures were performed by a single-surgeon team at Health Sciences North (Sudbury, Ontario, Canada). Inclusion criteria were T1-3 or downstaged T4 mid- and low-rectal lesions. Cases of non-neoplastic disease were excluded. Outcomes assessed included mesorectal integrity, margin status, operative time, complications, morbidity, length of stay and 30-day readmission.
A total of 70 cases were included. Patients were divided into early (27 patients, 14 males; mean age 60.74 ± 9.77 years) and late (43 patients, 29 males; mean age 63.48 ± 10.85 years) cohorts. During the early phase, procedural modifications including regular takedown of the splenic flexure, intra-corporeal division of the mesentery, liberal use of a Pfannenstiel incision for extraction, abundant washing of the surgical field and regular use of the ICG technology were progressively introduced. There was no mortality nor statistically significant difference between the early and late cohort in terms of morbidity (33.3 vs 39.4% p = 0.727), anastomotic leak (14.8 vs 4.6% p = 0.19), operating time (5.05 ± 1.26 vs 4.96 ± 1.14 h p = 0.755), length of stay (4.0 ± 2.54 vs 4.81 ± 3.63 days p = 0.394) and CRM negative margin (96.3 vs. 97.7% p = 0.999), and no incomplete specimens were obtained on either cohort.
This study confirms the safety and effectiveness of single-surgeon implementation of taTME technique. Technical challenges experienced in this setting were not obstacles for further refinement and to establish a tendency towards better outcomes. Overcoming technical challenges is possible, familiarity with taTME is slow yet progressive, and improvement tends to occur with experience.
经肛门全直肠系膜切除术(taTME)是一种安全有效的技术。我们已经在单外科医生环境中逐步开发了一种系统方法。本研究旨在比较我们的早期与晚期单外科医生 taTME 经验,并介绍对实现 taTME 计划至关重要的技术和后勤方面的修改。
回顾性分析了 2015 年 6 月至 2016 年 9 月(早期队列)接受 taTME 的 27 例患者和 2016 年 10 月至 2017 年 9 月(晚期队列)接受 taTME 的 43 例患者的前瞻性收集数据。手术由单外科医生团队在安大略省萨德伯里的健康科学北(Health Sciences North)进行。纳入标准为 T1-3 或降期 T4 中低位直肠病变。排除非肿瘤性疾病病例。评估的结果包括直肠系膜完整性、切缘状态、手术时间、并发症、发病率、住院时间和 30 天再入院率。
共纳入 70 例。患者分为早期(27 例,14 例男性;平均年龄 60.74±9.77 岁)和晚期(43 例,29 例男性;平均年龄 63.48±10.85 岁)队列。在早期阶段,逐步引入了程序性修改,包括常规切除脾曲、腔内肠系膜分离、广泛使用 Pfannenstiel 切口提取、大量冲洗手术区域和常规使用 ICG 技术。早期和晚期队列在发病率(33.3%比 39.4%,p=0.727)、吻合口漏(14.8%比 4.6%,p=0.19)、手术时间(5.05±1.26 比 4.96±1.14 小时,p=0.755)、住院时间(4.0±2.54 比 4.81±3.63 天,p=0.394)和 CRM 阴性切缘(96.3%比 97.7%,p=0.999)方面均无死亡或统计学显著差异,并且两个队列均未获得不完整的标本。
本研究证实了单外科医生实施 taTME 技术的安全性和有效性。在这种情况下遇到的技术挑战并不是进一步改进和建立更好结果趋势的障碍。克服技术挑战是可能的,对 taTME 的熟悉程度缓慢但逐步提高,并且随着经验的增加往往会有所改善。